Related Experiment Videos
Effect of partial testosterone replacement or thymosin on anti-DNA in castrated (NZB X NZW)F1 males
Abstract:
Castration of young (3-week-old) but not older (3-month-old) male (NZB X NZW)F1 mice was associated with autoantibody production similar to that of untreated female littermates. The castration-induced disease provided a unique model for the evaluation of therapeutic modalities during the first 9 months of life. Castrated male (NZB X NZW)F1 mice were treated with either long-term thymosin (fraction 5) or testosterone for different periods of time. Continuous testosterone replacement abolished the autoimmune disease-accelerating effects of castration at 3 weeks. Brief treatment during either the early or the later periods of life of castrated (NZB X NZW)F1 males was insufficient to prevent accelerated anti-DNA production. Thymosin treatment, when started at the time of castration and continued through life, abolished the rise in anti-DNA. These studies suggest that androgens work throughout the first 7 months of life of the mouse to suppress anti-DNA and that lack of androgens for a relatively brief period allows anti-DNA production to be initiated. Once initiated it cannot be completely suppressed. The cellular basis of the fixed aspect of this process is unknown. A possible role of the thymus is suggested by the ability of thymosin to suppress anti-DNA.
Insights
Early castration in male mice triggers autoimmune disease, similar to females. Continuous testosterone or lifelong thymosin treatment prevents this, suggesting androgens suppress autoantibodies until around 7 months.
Area of Science:
- Immunology
- Endocrinology
- Autoimmune Diseases
Background:
- Castration of young male (NZB X NZW)F1 mice induces autoantibody production.
- This castration-induced autoimmune response mimics that seen in female mice.
- This model is valuable for studying therapeutic interventions in early life autoimmune conditions.
Purpose of the Study:
- To investigate the role of androgens and thymosin in modulating autoimmune disease development after early castration.
- To evaluate the efficacy of testosterone replacement and thymosin treatment in preventing or reversing castration-induced autoimmunity.
Main Methods:
- Castration of young (3-week-old) and adult (3-month-old) male (NZB X NZW)F1 mice.
- Treatment of castrated mice with long-term thymosin (fraction 5) or testosterone.
- Assessment of autoantibody production, specifically anti-DNA antibodies.
Main Results:
- Castration at 3 weeks, but not 3 months, induced autoantibody production.
- Continuous testosterone replacement prevented the autoimmune acceleration caused by early castration.
- Lifelong thymosin treatment initiated at castration abolished the rise in anti-DNA antibodies.
- Brief testosterone treatment was insufficient to prevent accelerated anti-DNA production.
Conclusions:
- Androgens suppress anti-DNA antibody production throughout the first 7 months of mouse life.
- A temporary androgen deficiency can initiate autoimmune responses that are difficult to reverse.
- Thymosin shows potential in suppressing autoimmune disease development, possibly through thymus-related mechanisms.